95667-Acth High Risk Pregnan.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

95667-Acth High Risk Pregnan.Pdf Fetal Diagn Ther 2006;21:528–531 Received: July 12, 2005 Accepted after revision: January 19, 2006 DOI: 10.1159/000095667 Published online: September 12, 2006 The Effectiveness of Adrenocorticotropin Repeated Doses in High Risk Pregnancies M. Klimek Department of Gynecology and Infertility Clinic of Jagiellonian University, Krakow , Poland Key Words higher newborn mass and length than patients who re- Adrenocorticotropin Preterm birth Oxytocinase ceived a series of three hormonal injections as well as Hormonal therapy control women who had no clinical or laboratory indica- tion for such therapy. Conclusions: ACTH-depot injection results in the oxytocinase increased serum level, a de- Abstract creased number of abortion and preterm deliveries and Objective: The aim of this study was to assess the effect prolonged duration of pregnancy. Single repeated doses of two kinds of adrenocorticotropin (ACTH)-depot re- of the ACTH-depot therapy had statistically signifi cant peated doses administered to pregnant women who un- better results in the prolongation of pregnancy, newborn derwent infertility treatment. Material and Methods: The mass and length than a serial hormonal dosage. study population included 424 pregnant women with Copyright © 2006 S. Karger AG, Basel singletons. Two hundred and forty-two women received repeated 0.5 mg doses of ACTH, whereas 182 women also were treated for infertility but did not receive any Introduction therapy. The ACTH-treated patients were subdivided into two subgroups: (1) 142 patients received only series The benefi cial effects of the antenatal ad r enocortico- of three 0.5 g ACTH-depot injections every other day in tropin (ACTH)-depot and corticosteroids have been the fi rst and/or second trimester with occasionally single known, respectively for more than 40 [1] and 30 years [2] , ACTH-depot doses in the third trimester, (2) 100 patients but still only a small part, i.e., 25% of potential patients received only single 0.5 mg ACTH-depot doses for the are exposed to the hormonal therapy. The prenatal ste- entire duration of pregnancy. Clinical symptoms of roid therapy is believed to mimic the exposure to endog- threatened abortion and preterm delivery as well as very enous corticosteroids, which can easily be done by the low or decreasing levels of serum oxytocinases were in- ACTH-depot therapy. What is more, the betamethasone dications for the hormonal therapy. Low oxytocinase or dexamethasone use is not recommended in cases of serum levels, recurrent abortion and preterm delivery gestational age !28 weeks or 134 weeks, multiple gesta- characterize pregnant women with hypothalamic insuf- tions, delivery likely in !48 h or 67 days, premature rup- fi ciency. Results: Women who received only single dos- ture of membranes, and fetal and maternal complications es of the ACTH-therapy for the entire duration of preg- (i.e., diabetes, hypertension, or infection) [3–6] . The men- nancy had a statistically signifi cant longer gestation, and tioned factors do not eliminate the ACTH-depot therapy © 2006 S. Karger AG, Basel Marek Klimek MD, PhD 1015–3837/06/0216–0528$23.50/0 Department of Gynecology and Infertility Clinic of Jagiellonian University Fax +41 61 306 12 34 23 Kopernik Str E-Mail [email protected] Accessible online at: PL–31-501 Krakow (Poland) www.karger.com www.karger.com/fdt Tel. +4812 424 8528, Fax +4812 424 8585, E-Mail [email protected] [7, 8] because it uses natural endogenous corticoids and The evaluation of neonate maturation according to K index is therefore safe and can be used multiply during all tri- (Klimek index) was performed [17] . The estimation of the follow- mesters of pregnancy, not only 67 days before labor. ing features was included: the distribution of lanugo, the presence of plantar creases, the range of breast nipple, the position of ex- Additionally, the hormonal and enzymatic production tremities, the size of elbow angle, and the range of the elbow dislo- in the placenta is crucial in the mutual maternal-fetal cation to the midline. The range of newborn maturity was deter- neuro-immuno-endocrinal conditionings, especially the mined using the scale of 0, 1 and 2 points K: well-matured 9–12 synthesis and the supply of the oxytocinase (cystinoami- points K, low-matured 6–8 points K and premature infant less than nopeptidase-CAP ) and isooxytocinase (CAP ) concen- 6 points K. 1 2 The oxytocinase serum levels (CAP) of pregnant women were trations in the mother’s blood. Both enzymes are induced analyzed according to the Tuppy and Nesvadba method modifi ed by the same neurohormones whose production increases by Klimek, described in former publications [14, 15] . The results as the pregnancy progresses. The biochemical method of are presented in international units: mol/l/min. pregnancy monitoring and the birth-term determination The distribution of variables in the examined groups of women checked with the use of the Shapiro-Wilk test showed that all of by the evaluation of oxytocinase (CAP ) and isooxytoci- 1 them were different from normal. Therefore, non-parametric test- nase (CAP 2 ) serum levels increasing until labor was used ing was employed. Statistical signifi cance between the groups was [9, 10] . Only the physiological depletion of the adaptive determined by the Kruskal-Wallis analysis of variance (ANOVA) possibility of the whole placenta before labor shifts the test. The Mann-Whitney U test was then used as applicable. The balance to the hormones, which has long been described Spearman rank test was used to evaluate interclass correlation coef- fi cients. All calculations were carried out with the use of STATIS- as an ‘enzymatic block’ basing on the example of the oxy- TICA software v. 6 (StatSoft, USA, 2001). tocin-oxytocinase system [11, 12] . On the basis of the changes in the maternal CAP 1 and CAP 2 levels one can, among other things, assess when fetal death might occur Results or whether pregnancy is threatened only by abortion or preterm birth. When treatment is undertaken, the en- Table 1 presents the characteristics of study groups zymes become the most important element of its moni- I–III. No differences were found between these groups in toring, particularly in the hormone stimulation of the the mother’s age, the obstetrical history and oxytocinase maturation of the fetal respiratory system [1, 13–16] . and isooxytocinase serum levels before labor, the range The aim of this study was to determine the effect of of newborn maturation (K index) and the postpartum two kinds of repeated 0.5 mg doses of the ACTH-depot adaptation (Apgar) score. The average newborns’ ages, therapy: (1) series of three injections every other day and masses and lengths differed statistically and were ob- (2) single doses with an interval of at least 1 week between served to be the highest in group II and the lowest in group injections. The differences between them have not been I. Group II was statistically signifi cantly 1.54 more fre- previously reported. The clinical effect of a single 0.5 mg quently administered single doses of the ACTH-depot dose of ACTH-depot lasts ca. 48 h while the series of three and the average pregnancy duration time was statistical- doses covers 1 week. Low or decreasing levels of oxytoci- ly signifi cant 4.3 days elongated, the fetuses mass was nases (CAP 1 and CAP 2 ) or clinical symptoms of threat- 247 g higher and the lengths were 1.4 cm longer than in ened gestation is an indication for the ACTH-depot ther- group I. apy. Average values reached by group III, without the ad- ministration of the ACTH-depot therapy, were between the values reached by groups I and II with respect to the Materials and Methods pregnancy duration time and the newborn state range, but represented the statistically signifi cant highest CAP 1 Prospective study performed between 2001 and 2004 included and CAP prepartal value. a group of 424 women with a singleton pregnancy aged 30.1 8 4.7 2 (19–44) years, which were classifi ed into three following groups: The control group in comparison to I and II subgroup Group I = 142 pregnant women treated by a series of three 0.5 mg women had two times fewer abortions in the past and the ACTH-depot injections every other day with single supplementary highest prepartal levels of CAP 1 and CAP 2 with the same doses in the third trimester of pregnancy; Group II = 100 pregnant newborn adaptation and maturity points ( table 1 ). In women treated only by single ACTH-depot doses not more fre- treated women better results were obtained in the single quently than once a week for the entire duration of pregnancy; Group III = 182 women also after the infertility treatment, who did dosage group, however, the rising of the dose caused the not require the substitution hormonal therapy (control group). In decreasing of the number of cases of cervical cerclages all patients informed consent was obtained. and the increasing number of cases of spontaneous onsets Effectiveness of Adrenocorticotropin in Fetal Diagn Ther 2006;21:528–531 529 High Risk Pregnancies Table 1. The characteristics of prospectively studied groups I, II and III Groups I (n = 142) II (n = 100) III control group (n = 182) Mothers’ average age, years 29.684.3 (21–44) 31.084.6 (20–43) 30.085.1 (19–46) Number of gestations 1.981.3 (1–8) 2.081.2 (1–8) 1.881.3 (1–7) Number of deliveries 1.280.6 (1–4)III 1.280.6 (1–4)III 1.480.8 (1–5)I, II Number of abortions 0.781.0 (0–7) 0.880.9 (0–5) 0.480.8 (0–4) Number of children 1.280.5 (0–4) 1.280.6 (0–5) 1.480.7 (0–4) Total number of ACTH injections during gestation 5.282.8 (1–14)II 9.183.5 (1–19)I – III III I, II CAP1, ␮mol/l/min 7.782.5 (1.8–15.6) 7.882.5 (1.8–14.0) 8.982.4 (3.4–16.2) III I CAP2, ␮mol/l/min 6.481.8 (2.8–12.0) 6.581.8 (2.8–12.5) 6.881.9 (3.2–12.8) Length of gestation, days 270.7822.0 (222–305)II 275.0811.0 (230–303)I 272.6812.0 (214–306) Newborn mass, g 3,2308504 (1,510–4,200)II, III 3,4778420 (1,840–4,400)I, III 3,3418480 (1,780–4,350)I, II Length, cm 53.683.2 (42–64)I, II 55.082.5 (46–60)I, III 54.482.6 (43–59)I, II Apgar, points 9.580.8 (4–10) 9.780.9 (4–10) 9.781.5 (4–10) Klimek, points 8.881.6 (4–12) 8.981.7 (4–11) 8.881.7 (3–12) I–III The difference was statistically signifi cant (p < 0.05).
Recommended publications
  • Aminopeptidase (Oxytocinase) and Arylamidase of Human Serum During Pregnancy Saara Lampelo and T
    Fractionation and characterization of cystine aminopeptidase (oxytocinase) and arylamidase of human serum during pregnancy Saara Lampelo and T. Vanha-Perttula Department ofAnatomy, University ofKuopio, P.O. Box 138, 70101 Kuopio 10, Finland Summary. Cystine aminopeptidase and arylamidase activities in human serum were determined by enzymic hydrolysis of l-cystine-di-\g=b\-naphthylamide(CysNA) and l\x=req-\ leucine-\g=b\-naphthylamide(LeuNA), respectively. The activities of both enzymes increased during pregnancy, cystine aminopeptidase 12\m=.\5-foldand arylamidase 8\m=.\3\x=req-\ fold. Serum CysNA and LeuNA hydrolysing aminopeptidases were separated by gel filtration on Sepharose 6B. Serum from non-pregnant women (control) contained arylamidase (Ic), which hydrolysed LeuNA and (weakly) CysNA, and cystine amino- peptidase II, hydrolysing only CysNA. During pregnancy a new enzyme appeared in maternal serum and showed cystine aminopeptidase and arylamidase activity (Im). Maternal serum Enzyme(s) I had higher pH optima (6\m=.\5with CysNA; 7\m=.\5with LeuNA) and higher molecular weights (309 000) than arylamidase Ic (pH optima at 5\m=.\52\p=n-\5\m=.\5with CysNA and 7\m=.\0with LeuNA; mol.wt ~130 000). Arylamidase Ic was more sensitive to l-methionine, but more resistant to heat than maternal serum Enzyme(s) I. Both control and maternal serum Enzyme(s) I were inhibited by EDTA, but were re-activated by Zn2+ and Co2+ with LeuNA and CysNA as sub- strates and by Ni2+ with CysNA. Cystine aminopeptidase Im and arylamidase Im may be a single enzyme although differences were obtained in pH optima and re- activation by Ni2+ after EDTA treatment.
    [Show full text]
  • 2017 ACT Newsletter (PDF)
    AMERICAN COLLEGE OF THERIOGENOLOGISTS Newsletter Spring 2017 Dear ACT Diplomates, Greetings to all. It has been another busy year for the committees and the executive board. The Training and Credentialing Committee worked diligently and approved a total of 18 candidates to sit Therio Conference for the certifying exam in August 2017 in Fort Collins, 2017 Fort Collins | August 2-5 Colorado. The Examination Committee worked hard and formulated the certifying exam for this year which will be completely computerized. Reminder As you may recall, a total of 27 candidates sat for the Ballot deadline is June 15 exam in Asheville in August 2016. Of these, 15 candidates successfully passed the examination; six of which did not fulfill all requirements for becoming a diplomate in the In this issue ACT. So far, only three of these have completed all of the 2 Welcome new diplomates requirements. I request their mentors help these candidates to complete their requirements at the 2 In memoriam earliest possible date. 3 Certifying Examination A total of 71 scientific abstracts were submitted this year for consideration for oral presentation at Committee report the annual Therio Conference. Considering the submissions of previous years, the total number of 3 Scientific Abstract submissions is consistent. Thanks to all who submitted abstracts this year and I am very eager to Information Committee listen to the fruitful outcome of your hard work in August. report This year, many diplomates expressed interest to serve on the executive board. This is a welcome 4 McCue named change. We have an excellent pool of candidates this year.
    [Show full text]
  • Radioimmunological and Clinical Studies with Luteinizing Hormone Releasing Hormone (Lrh) Stellingen
    INIS-mf--10930 RADIOIMMUNOLOGICAL AND CLINICAL STUDIES WITH LUTEINIZING HORMONE RELEASING HORMONE (LRH) STELLINGEN 1) Although the classical translocation model for steroid - receptor interactions has been convincingly dlsproven, the concept of an exclusive nuclear localization of both occupied and un-occupied receptor needs further validation. Raara et al. Eur.J.Cancer.Clin.Oncol. 16:1,1982 Raam et al. Breast Cancer Res.Treat. 3:179,1983 Welshons et al. Nature 307:747,1984 Welshons et al. Endocrinology 117:2140,1985 Roberstson et al. Endocr.Soc.Meeting 198S, Abstract Book, p20 2) The mode of administration will determine if LH-releasing agonists will act in a stimulatory or inhibitory manner. Sopelak, Collins & Hodgen, J.Clin.Endocr.Metab. 65:557,1986 Crowley et al. Rec.Progr.Horm.Res. 41:473,1985 Monroe et al. Fertil.Sterll. 43:361,1985 3) Hyperprolactinaemia need not result in galactorrhea and even in its mild or transient forms it may cause amenorrhea. Bohnet et al. Clin.Endocrinology 5:25,1976 Ben-David et al. J.Clin.Endocr.Metab. 57:442,1983 Suginami et al. J.Clin.Endocr.Metab. 62:899,1986 4) The presence of oestradiol and oestradiol receptors in Saccharo- myces cerevisae implies a physiological function of these compounds in yeast. However, since the presence of oestradiol may in fact be due to contaminated media components, caution should be exercised in interpreting the results. Feldman et al. Science 224:1119,1984 Miller et al. Endocrinology 119:1362,1986 5) The statement that "in order to induce potassium sensitivity of the phosphorylated intermediate of Na/K ATPase, a simultaneous binding of sodium is required", is in error.
    [Show full text]
  • Hormonal Physiology of Childbearing: Evidence and Implications for Women, Babies, and Maternity Care
    Hormonal Physiology of Childbearing: Evidence and Implications for Women, Babies, and Maternity Care Sarah J. Buckley January 2015 Childbirth Connection A Program of the National Partnership for Women & Families About the National Partnership for Women & Families At the National Partnership for Women & Families, we believe that actions speak louder than words, and for four decades we have fought for every major policy advance that has helped women and families. Today, we promote reproductive and maternal-newborn health and rights, access to quality, affordable health care, fairness in the workplace, and policies that help women and men meet the dual demands of work and family. Our goal is to create a society that is free, fair and just, where nobody has to experi- ence discrimination, all workplaces are family friendly and no family is without quality, affordable health care and real economic security. Founded in 1971 as the Women’s Legal Defense Fund, the National Partnership for Women & Families is a nonprofit, nonpartisan 501(c)3 organization located in Washington, D.C. About Childbirth Connection Programs Founded in 1918 as Maternity Center Association, Childbirth Connection became a core program of the National Partnership for Women & Families in 2014. Throughout its history, Childbirth Connection pioneered strategies to promote safe, effective evidence-based maternity care, improve maternity care policy and quality, and help women navigate the complex health care system and make informed deci- sions about their care. Childbirth Connection Programs serve as a voice for the needs and interests of childbearing women and families, and work to improve the quality and value of maternity care through consumer engagement and health system transformation.
    [Show full text]
  • (A-LAP)/ER-Aminopeptidase-1
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 580 (2006) 1833–1838 Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1 Yoshikuni Gotoa,b, Akira Hattoria, Yasuhiro Ishiib, Masafumi Tsujimotoa,* a Laboratory of Cellular Biochemistry, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan b Laboratory of Applied Protein Chemistry, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-0054, Japan Received 15 December 2005; revised 21 January 2006; accepted 15 February 2006 Available online 24 February 2006 Edited by Irmgard Sinning searching databases [3,4]. Structural and phylogenetic analyses Abstract The adipocyte-derived leucine aminopeptidase (A- LAP)/ER aminopeptidase-1 is a multi-functional enzyme belong- indicated that P-LAP, A-LAP and L-RAP are most closely re- ing to the M1 family of aminopeptidases. It was reported that the lated among the M1 family of aminopeptidases, which contain polymorphism Lys528Arg in the human A-LAP gene is associ- GAMEN and HEXXH(X)18E consensus motifs. Therefore we ated with essential hypertension. In this study, the role of proposed that they should be classified into ‘‘the oxytocinase Lys528 in the enzymatic activity of human A-LAP was exam- subfamily of M1 aminopeptidases’’ [5]. ined by site-directed mutagenesis. Among non-synonymous poly- A-LAP is a multi-functional aminopeptidase shown to play morphisms tested, only Lys528Arg reduced enzymatic activity. roles in the regulation of blood pressure, angiogenesis and The replacement of Lys528 with various amino acids including antigen presentation to MHC class I molecules [5–9].
    [Show full text]
  • Actions of Mechanisms Receptor Mechanisms 151, 213 Signal
    Cambridge University Press 0521831482 - Birth, Distress and Disease: Placental-Brain Interactions Edited by Michael L. Power and Jay Schulkin Index More information Index actions of mechanisms animal models receptor mechanisms 151, 213 diversity 103 signal transduction mechanisms 210, steroidogenesis 104 213 antenatal glucocorticoid exposure see prenatal actions on the gene 212, 220 glucocorticoid exposure activator protein 2 (AP-2) 164 antenatal glucocorticoids on CNS adenylate cyclase activity 24, 41 antioxidants 161 adipoinsular axis 130, 131 dexamethasone 162, 163 adipose tissue structural effects 160 adiponectin 156 anterior pituitary cells 21, 24 muscle and fat 154 anthropoid primates 6, 90, 94, 104, 185 leptin 155 anxiety-related behaviors 151, 162, 259 adrenal glands 92, 96, 247 arginine vasopressin (AVP) 23, 115, 159, 202, adrenal hormones 30, 185, 191 231 adrenal steroids AVP gene expression 208, 217, 218 glucocorticoids 242 AVP gene 220–223, 227 mineralocorticoids 243 CRH neuroendocrine neurons 209, 214, adrenalectomized (ADX) 10, 93, 151, 205, 227 206, 207, 228, 231 rapid negative-feedback signal 227 adrenocorticotrophic hormone (ACTH) AVP 115, 159, 202–206, 208–209, 216–223, basal conditions 226–227 ACTH secretion 217, 218, 221, 226, 227 CRH 8, 21, 79, 95, 116, 162, 185, 205, corticosterone’s long-term actions 219 206 CRH gene expression 218, 225–228 median eminence (ME) 115, 203 CRH gene transcription 220 adult pancreatic morphology 127 HPA axis 218 adult-onset disease neuroendocrine terminals 218 fetal physiology 2 RNA transcripts
    [Show full text]
  • In Vitro Validation of Peptide-T3 Conjugates As a Treatment Option for MCT8-Deficiency Via a “Trojan Horse”-Like Mechanism
    In vitro validation of peptide-T3 conjugates as a treatment option for MCT8-deficiency via a “Trojan Horse”-like mechanism vorgelegt von Dipl.-Ing. Sarah Paisdzior geb. in Berlin von der Fakultät III – Prozesswissenschaften der Technischen Universität Berlin zur Erlangung des akademischen Grades Doktor der Naturwissenschaften - Dr. rer. nat. – genehmigte Dissertation Promotionsausschuss: Vorsitzender: Prof. Dr. Juri Rappsilber Gutachter: Prof. Dr. Roland Lauster Gutachterin: Prof. Dr. Heike Biebermann Gutachter: Prof. Dr. Jens Kurreck Tag der wissenschaftlichen Aussprache: 14.12.2018 Berlin 2019 This project was founded by the Deutsche Forschungsgesellschaft (DFG) in the priority programme Thyroid Trans Act SPP1629: KR 1710/5 Abstract Cells use transmembrane transporters to take up substances that are important for functionality and survival of the organism. One example of these substances are thyroid hormones (THs), tyrosine-based hormones containing iodine that are released by the thyroid gland. The most important THs, thyroxine (T4) and triiodothyronine (T3) are transported in and out of cells by several transporters including the very specific TH transporter monocarboxylate transporter 8 (MCT8). This transporter is expressed in the central nervous system (CNS) among other tissues. Unfortunately, several inactivation mutations of the gene SLC16A2 (coding for MCT8 on the X-chromosome) have been found in mostly male patients. They suffer from severe psychomotor retardation, known as Allan-Herndon-Dudley syndrome (AHDS), due to lack of THs during fetal development. Since MCT8 is the crucial transporter for the influx of THs into the brain, the patients are rendered hypothyroid in the CNS, but hyperthyroid in the periphery. Treatment options with TH derivates are currently limited, so development of a new therapy is urgently needed.
    [Show full text]
  • Kidney Aminopeptidase Activities Are Related to Renal Damage In
    Journal of Clinical and Molecular Medicine Research Article ISSN: 2516-5593 Kidney aminopeptidase activities are related to renal damage in experimental breast cancer José Manuel Martínez-Martos1, María del Pilar Carrera1,2, Rafael Sánchez-Agesta1,3, María Jesús García1,4 and María Jesús Ramírez-Expósito1* 1Experimental and Clinical Physiopathology Research Group CTS-1039; School of Health Sciences, Department of Health Sciences, University of Jaén, Campus Universitario Las Lagunillas, Jaén, Spain 2Department of Nursing, University of Córdoba, Córdoba, Spain 3Unit of Clinical Biochemistry, Complejo Hospitalario de Jaén, Jaén, Spain 4Laboratorio Central de Sanidad Animal, Santafé, Granada, Spain Abstract Background: Several peptides act in kidney, being the angiotensins of the renin-angiotensin-aldosterone system the best described. However, other lesser known include vasopressin, oxytocin, gonadotrophin releasing hormone or tyrotrophin releasing homone, with renal functions mainly unresolved. We had described changes in several circulating and tissue aminopeptidase activities both in women and rats with breast cancer. These changes have been involved not only in breast disease, but also in other functions of concomintantly affected tissues. Aim of the study: To analyze renal functions mediated by biologically active peptides in animals with breast cancer through the analysis of their regulatory aminopeptidases. Methods: Soluble and membrane-bound forms of aminopeptidase N, aminopeptidase B, aspartyl aminopeptidase, aminopeptidase A, insulin-regulated aminopeptidase, cystinyl aminopeptidase and pyroglutamyl aminopeptidase specific activities are measured in renal cortex and medulla of rats with mammary tumors induced by N-methyl-N-nitrosourea (NMU). Plasma and urine electrolytes (sodium, potassium, chloride, calcium, phosphorus), non-protein nitrogenous compounds (urea, creatinine, uric acid), albumin and total protein, are measured as markers of renal function.
    [Show full text]
  • ERAP1) Reveal the Molecular Basis for N-Terminal Peptide Trimming
    Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming Grazyna Kochana,1, Tobias Krojera,1, David Harveyb, Roman Fischerc, Liye Chend, Melanie Vollmara, Frank von Delfta, Kathryn L. Kavanagha, Matthew A. Brownb,e, Paul Bownessb,d, Paul Wordsworthb, Benedikt M. Kesslerc, and Udo Oppermanna,b,2 aStructural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, Headington OX3 7DQ, United Kingdom; bBotnar Research Center, National Institute for Health Research Oxford Biomedical Research Unit, Oxford OX3 7LD, United Kingdom; cHenry Wellcome Building for Molecular Physiology, University of Oxford, Oxford OX3 7BN, United Kingdom; dWeatherall Institute for Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom; and eUniversity of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane 4102, Australia Edited* by Marc Feldmann, Imperial College London, United Kingdom, and approved March 15, 2011 (received for review January 26, 2011) Endoplasmatic reticulum aminopeptidase 1 (ERAP1) is a multifunc- However, based on biochemical studies a model of ERAP1 activ- tional enzyme involved in trimming of peptides to an optimal ity was suggested that involves the binding of a 9–15-mer peptide length for presentation by major histocompatibility complex to the active site of ERAP1, where successively N-terminal resi- (MHC) class I molecules. Polymorphisms in ERAP1 have been asso- dues are cleaved off until the N-terminal part of the peptide is no ciated with chronic inflammatory diseases, including ankylosing longer reaching the active site. The rate at which this process spondylitis (AS) and psoriasis, and subsequent in vitro enzyme occurs appears to be peptide sequence specific (13, 14).
    [Show full text]
  • The Endocrinology of the Brain
    ID: 18-0367 7 12 G Leng The endocrinology of the 7:12 R275–R285 brain REVIEW The endocrinology of the brain Gareth Leng Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK Correspondence should be addressed to G Leng: [email protected] Abstract The brain hosts a vast and diverse repertoire of neuropeptides, a class of signalling Key Words molecules often described as neurotransmitters. Here I argue that this description f neuropeptides entails a catalogue of misperceptions, misperceptions that feed into a narrative in which f hypothalamus information processing in the brain can be understood only through mapping neuronal f neuroendocrinology connectivity and by studying the transmission of electrically conducted signals through f pituitary chemical synapses. I argue that neuropeptide signalling in the brain involves primarily autocrine, paracrine and neurohormonal mechanisms that do not depend on synaptic connectivity and that it is not solely dependent on electrical activity but on mechanisms analogous to secretion from classical endocrine cells. As in classical endocrine systems, to understand the role of neuropeptides in the brain, we must understand not only how their release is regulated, but also how their synthesis is regulated and how the sensitivity of their targets is regulated. We must also understand the full diversity of Endocrine Connections effects of neuropeptides on those targets, including their effects on gene expression. (2018) 7, R275–R285 Introduction Endocrinology is the study of hormones, secreted by Between these two, dangling below the brain endocrine glands in one part of the body, which travel and bathed in blood, is the pituitary gland, and in the blood and have prolonged effects on other parts of dangling between neuroscience and endocrinology is the body – effects that are determined by tissue-specific neuroendocrinology, born of Geoffrey Harris’ insights in expression of their receptors.
    [Show full text]
  • Role of Laeverin in the Pathophysiology of Preeclampsia. —
    Faculty of Health Sciences Department of Clinical Medicine Role of laeverin in the pathophysiology of preeclampsia. Role of laeverin in the pathophysiology of preeclampsia - Mona Nystad in the pathophysiology of preeclampsia Role of laeverin — Mona Nystad A dissertation for the degree of Philosophiae Doctor, May 2018 ISBN 978-82-7589-582-8 ROLE OF LAEVERIN IN THE PATHOPHYSIOLOGY OF PREECLAMPSIA Mona Nystad A dissertation for the degree of Philosophiae Doctor – May 2018 Women’s Health and Perinatology Research Group Department of Clinical Medicine Faculty of Health Sciences UiT – The Arctic University of Tromsø Cover photos Picture of the baby and the placenta on the front page is reproduced with the courtesy of the photographer and midwife Emma Jean (Emma Jean Photography, Brisbane, Australia) and the parents of the baby. Pictures in the lower column are immunofluorescence pictures of trophoblast cells, which are the major constituents of the placenta. Left picture is of cytotrophoblast cells from normal placenta stained with green fluorescence antibodies against laeverin protein (in plasma membrane). Middle picture is of extravillous trophoblast cells of normal placenta stained with red fluorescence antibodies against laeverin (in plasma membrane) and green fluorescence antibodies against cytokeratin 7 protein (in cytoplasma). Right picture is of cytotrophoblast cells from placenta of a preeclampsia patient stained with green fluorescence antibodies against laeverin protein (in cytoplasma). Cells are counterstained with DAPI II (blue)
    [Show full text]
  • POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii
    POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii http://rcin.org.pl WSKAZÓWKI DLA AUTORÓW Kwartalnik „Postępy Biochemii” publikuje artykuły monograficzne omawiające wąskie tematy, oraz artykuły przeglądowe referujące szersze zagadnienia z biochemii i nauk pokrewnych. Artykuły pierwszego typu winny w sposób syntetyczny omawiać wybrany temat na podstawie możliwie pełnego piśmiennictwa z kilku ostatnich lat, a artykuły drugiego typu na podstawie piśmiennictwa z ostatnich dwu lat. Objętość takich artykułów nie powinna przekraczać 25 stron maszynopisu (nie licząc ilustracji i piśmiennictwa). Kwartalnik publikuje także artykuły typu minireviews, do 10 stron maszynopisu, z dziedziny zainteresowań autora, opracowane na podstawie najnow­ szego piśmiennictwa, wystarczającego dla zilustrowania problemu. Ponadto kwartalnik publikuje krótkie noty, do 5 stron maszynopisu, informujące o nowych, interesujących osiągnięciach biochemii i nauk pokrewnych, oraz noty przybliżające historię badań w zakresie różnych dziedzin biochemii. Przekazanie artykułu do Redakcji jest równoznaczne z oświadczeniem, że nadesłana praca nie była i nie będzie publikowana w innym czasopiśmie, jeżeli zostanie ogłoszona w „Postępach Biochemii”. Autorzy artykułu odpowiadają za prawidłowość i ścisłość podanych informacji. Autorów obowiązuje korekta autorska. Koszty zmian tekstu w korekcie (poza poprawieniem błędów drukarskich) ponoszą autorzy. Artykuły honoruje się według obowiązujących stawek. Autorzy otrzymują bezpłatnie 25 odbitek swego artykułu; zamówienia na dodatkowe odbitki (płatne) należy zgłosić pisemnie odsyłając pracę po korekcie autorskiej. Redakcja prosi autorów o przestrzeganie następujących wskazówek: Forma maszynopisu: maszynopis pracy i wszelkie załączniki należy nadsyłać w dwu egzem­ plarzach. Maszynopis powinien być napisany jednostronnie, z podwójną interlinią, z marginesem ok. 4 cm po lewej i ok. 1 cm po prawej stronie; nie może zawierać więcej niż 60 znaków w jednym wierszu nie więcej niż 30 wierszy na stronie zgodnie z Normą Polską.
    [Show full text]